Steven P. Cohen, Chief of Pain Medicine at Johns Hopkins, Joins Releviate Therapeutics as Head of Its Scientific Advisory Board
Steven P. Cohen, Chief of Pain Medicine at Johns Hopkins, Joins Releviate Therapeutics as Head of Its Scientific Advisory Board Cohen’s Appointment Comes on the Heels of Releviate Therapeutics Closing Series A Funding SAN DIEGO – July 27, 2021 – Releviate™ Therapeutics, a bio-pharmaceutical company developing a novel human antibody-based approach to treating neuropathic